Drug Database
Back to search

Switzerland· 65222002

Cholib

A simvastatin and fenofibrate product containing simvastatinum, fenofibratum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 10 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C10BA04

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedCholibATCC10BA04REGISTER NO.65222002PACKS LISTED1CHECKEDSeptember 12, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about simvastatinum, fenofibratumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Simvastatin and fenofibrate is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA04 (simvastatin and fenofibrate), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 6 of them publish a price we can compare per daily dose
Search simvastatin and fenofibrate products by name

Simvastatin and fenofibrate · ATC C10BA04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
simvastatinum, fenofibratum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C10BA04
ATC class
Simvastatin and fenofibrate
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680652220020
    90 Stk
    CHF 68.25

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for simvastatin and fenofibrate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check simvastatin and fenofibrate against other medicinesHow interaction checks work

Simvastatin and fenofibrate · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Simvastatin and fenofibrate in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatin and fenofibrate products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Iceland · Cholib
  • Liechtenstein · Cholib
  • Norway · Cholib

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d7a60b68-2336-47a2-9749-bc2c324a0b5e
GET /v1/drugs/d7a60b68-2336-47a2-9749-bc2c324a0b5e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "simvastatinum 20 mg + fenofibratum 145 mg",
  "valid_from": "2014-11-01",
  "limitations": "[{\"description\":\"Als Begleittherapie zu einer Diät und körperlicher Bewegung bei erwachsenen Patienten mit hohem kardiovaskulären Risiko und gemischter Dyslipidämie, um die Triglyzeride abzusenken und die HDL-Cholesterinspiegel zu erhöhen, wenn die LDL-Cholesterinspiegel angemessen mit der entsprechenden Dosis der Simvastatin-Monotherapie eingestellt sind und die Kriterien entsprechend der Limitierung der Simvastatin-Monopräparate erfüllt sind.\",\"costApproval\":null,\"indication\":null,\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2022-08-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 145mg/20mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2014-11-01",
  "self_retention_pct": 10
}
API referenceMCP serverPlans

See everything about simvastatin and fenofibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console